T.E. Redelmeier
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in ⓘ
-
- Advanced Drug Delivery Systems 2
-
- Nanoparticle-Based Drug Delivery 4
- Co-authors
- Pieter R. Cullis (7 shared papers)Paul Richard Harrigan (4 shared papers)Sandra L. Schmid (2 shared papers)Marcel B. Bally (4 shared papers)Michael J. Hope (4 shared papers)Thomas D. Madden (3 shared papers)Igor Gonda (4 shared papers)David Cipolla (4 shared papers)
- Journals
- Journal of Pharmaceutical Sciences (2 papers)Chemistry and Physics of Lipids (2 papers)Biochemistry (2 papers)Biophysical Journal (2 papers)Molecular Biology of the Cell (1 paper)
- Partner nations
- CanadaAustraliaUnited States
In The Last Decade
T.E. Redelmeier
15 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 95
- Biomaterials 387
- Pharmaceutical Science 117
- Cell Biology 214
- Molecular Biology 845
- Oncology 146
Countries citing papers authored by T.E. Redelmeier
This map shows the geographic impact of T.E. Redelmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.E. Redelmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.E. Redelmeier more than expected).
Fields of papers citing papers by T.E. Redelmeier
This network shows the impact of papers produced by T.E. Redelmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.E. Redelmeier. The network helps show where T.E. Redelmeier may publish in the future.
Co-authors
The 25 scholars most cited alongside T.E. Redelmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 199 | |
| 2 | 1993 | 165 | |
| 3 | 1993 | 152 | |
| 4 | Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models. | 2000 | 137 |
| 5 | 1989 | 100 | |
| 6 | 2019 | 69 | |
| 7 | 1993 | 60 | |
| 8 | 2014 | 54 | |
| 9 | 1990 | 48 | |
| 10 | 2013 | 47 | |
| 11 | 2016 | 41 | |
| 12 | 1988 | 38 | |
| 13 | 1989 | 34 | |
| 14 | 1992 | 30 | |
| 15 | 2016 | 24 |
About T.E. Redelmeier
T.E. Redelmeier is a scholar working on Pharmaceutical Science, Biomaterials, Immunology and Allergy, Electrochemistry and Molecular Biology, having authored 15 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lipid Membrane Structure and Behavior (7 papers), Nanoparticle-Based Drug Delivery (4 papers), Advanced biosensing and bioanalysis techniques (2 papers), Molecular Sensors and Ion Detection (2 papers), RNA Interference and Gene Delivery (2 papers), Advanced Drug Delivery Systems (2 papers), Cellular transport and secretion (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Biomaterials (387 citations), Pharmaceutical Science (117 citations), Cell Biology (214 citations), Molecular Biology (845 citations) and Oncology (146 citations). T.E. Redelmeier has collaborated with scholars based in Canada, Australia and United States. Frequent co-authors include Pieter R. Cullis, Paul Richard Harrigan, Sandra L. Schmid, Marcel B. Bally, Michael J. Hope, Thomas D. Madden, Igor Gonda, David Cipolla, Lawrence D. Mayer and Hak‐Kim Chan. Their work appears in journals such as Journal of Pharmaceutical Sciences, Chemistry and Physics of Lipids, Biochemistry, Biophysical Journal and Molecular Biology of the Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.